Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Neurology

Epilepsy & Neurological Management in Idic15

At a Glance

Epilepsy affects over half of individuals with idic15 (Dup15q syndrome) and is often difficult to control with standard medications. Effective management requires a proactive approach, including tracking unique EEG patterns and exploring advanced treatments like neurostimulation or hormonal therapies.

Epilepsy is one of the most significant challenges for families living with idic15 and Dup15q syndrome, affecting approximately 55% of individuals [1][2]. These seizures are often refractory, meaning they are difficult to control with standard medications and require a specialized, proactive approach to management [1][3].

Link back to Home Page

The Seizure Trajectory

In many children with idic15, the journey with epilepsy begins in infancy. Understanding the common patterns can help you prepare for and respond to changes:

  • Infantile Spasms: These often appear as sudden “jackknife” clusters of movements. They are considered a medical emergency because they can lead to rapid developmental regression [4][2].
  • Risk of Evolution: Infantile spasms may resolve with treatment, but families and doctors should monitor closely for the potential development of other seizure types, such as atypical absences (staring spells) or “drop attacks” [1][5]. In some cases, this evolves into a complex epilepsy pattern known as Lennox-Gastaut Syndrome (LGS), though early intervention aims to mitigate this [2][5].
  • Atypical Presentation: Seizures in this syndrome can be diverse, including focal seizures or subtle staring episodes that may be mistaken for daydreaming [1][5].

A Unique Brain Signature: Beta Oscillations

One of the most striking features of idic15 is a specific pattern on the EEG called elevated beta oscillations (12-30 Hz) [6][7].

  • What it is: A high-frequency electrical “hum” in the brain that is almost always present in individuals with maternal Dup15q [5][8].
  • Why it matters: This biomarker is linked directly to the duplication of GABA genes [9][10]. It helps doctors confirm the diagnosis and provides a stable baseline to measure how the brain is responding to new treatments in clinical trials [7][11].

Managing Refractory Epilepsy

When traditional anti-seizure drugs (ASMs) fail, neurologists may explore more advanced or specialized strategies:

  • Hormonal Therapy: For infantile spasms, high-dose steroids or ACTH are considered first-line treatments [4][12].
  • Neurostimulation: Devices like Vagal Nerve Stimulation (VNS) or Responsive Neurostimulation (RNS) have shown success in reducing seizure frequency when medications are inadequate [3][13].
  • Emerging Drugs: Researchers are investigating new medications like soticlestat, though early results show that some patients may actually experience an increase in certain seizure types, highlighting the need for close monitoring [14].
  • Advanced Interventions: In exceedingly rare, extreme emergencies—such as life-threatening seizure clusters or catatonia (a severe state presenting as sudden mutism, extreme lethargy, or a refusal to eat or drink)—Electroconvulsive Therapy (ECT) is recognized as a rapidly effective option for stabilization [15][16].

Understanding the Risk of SUDEP

Sudden Unexpected Death in Epilepsy (SUDEP) is a difficult but necessary topic for families to discuss with their care team. It is crucial to understand that while SUDEP is a risk—particularly for those with poorly controlled convulsive seizures—many individuals with Dup15q syndrome live long, fulfilling lives.

Because refractory seizures carry inherent, unavoidable risks, safety focuses on what can be managed [17][18]:

  • Nighttime Supervision: Using baby monitors or specialized seizure-detection devices can help caregivers respond quickly to nighttime events [17][18].
  • Seizure Action Plans: Maintaining strict medication adherence and working with your doctor on a clear emergency plan is a vital, controllable factor for maximizing safety [19][20].
  • Open Dialogue: Frequent communication with your child’s neurologist about seizure frequency and nighttime safety is vital for mitigating risks [17][21].

Common questions in this guide

What types of seizures are common in idic15 syndrome?
Children with idic15 often experience infantile spasms early in life, which can appear as sudden clusters of movements. These can sometimes evolve into other types of seizures, such as staring spells, drop attacks, or a complex epilepsy pattern known as Lennox-Gastaut Syndrome.
What do elevated beta oscillations mean on my child's EEG?
Elevated beta oscillations are a specific high-frequency electrical pattern frequently seen on the EEGs of individuals with maternal Dup15q syndrome. This unique brain signature helps doctors confirm the diagnosis and provides a baseline to measure how well treatments are working.
What are the treatment options if standard anti-seizure medications fail?
When traditional medications are not enough, neurologists may explore other specialized treatments. These can include hormonal therapies like ACTH for infantile spasms, or neurostimulation devices such as Vagal Nerve Stimulation (VNS) to help reduce seizure frequency.
How can we manage the risk of SUDEP during the night?
While refractory seizures carry inherent risks, families can maximize safety by using nighttime supervision tools like specialized baby monitors or seizure-detection devices. Sticking strictly to prescribed medications and having a clear seizure action plan are also vital protective measures.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has an EEG confirmed the presence of the 'beta-band' oscillation biomarker in my child?
  2. 2.Does my child's current seizure pattern suggest an evolution toward other seizure types or syndromes like LGS?
  3. 3.At what point should we consider neurostimulation (like VNS) if medications continue to fail?
  4. 4.What is the specific plan for monitoring and maximizing safety during the night?
  5. 5.Are there any anti-seizure medications that we should specifically avoid due to a high risk of paradoxical reactions in idic15?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Spectrum of epilepsy and electroencephalogram patterns in idic (15) syndrome.

    Battaglia A, Bernardini L, Torrente I, et al.

    American journal of medical genetics. Part A 2016; (170(10)):2531-9 doi:10.1002/ajmg.a.37844.

    PMID: 27513709
  2. 2

    Electroclinical findings and long-term outcomes in epileptic patients with inv dup (15).

    Matricardi S, Darra F, Spalice A, et al.

    Acta neurologica Scandinavica 2018; (137(6)):575-581 doi:10.1111/ane.12902.

    PMID: 29363096
  3. 3

    Dramatic Response to Neurostimulation in Children With Medically Intractable Epilepsy Related to Pseudoisodicentric Chromosome 15q Duplication: A Case Series.

    Lockard T, Koh S, Thodeson DM

    Pediatric neurology 2025; (170()):129-132 doi:10.1016/j.pediatrneurol.2025.06.014.

    PMID: 40683199
  4. 4

    First-choice hormonal therapies for children with infantile epileptic spasms syndrome in South Asia: A network meta-analysis of randomized controlled trials.

    Devi N, Madaan P, Kandoth N, et al.

    Epilepsia open 2024; (9(6)):2037-2048 doi:10.1002/epi4.13086.

    PMID: 39513499
  5. 5

    Electro-clinical features in epileptic children with chromosome 15q duplication syndrome.

    Dangles MT, Malan V, Dumas G, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2021; (132(5)):1126-1137 doi:10.1016/j.clinph.2021.02.010.

    PMID: 33773177
  6. 6

    A Quantitative Electrophysiological Biomarker of Duplication 15q11.2-q13.1 Syndrome.

    Frohlich J, Senturk D, Saravanapandian V, et al.

    PloS one 2016; (11(12)):e0167179 doi:10.1371/journal.pone.0167179.

    PMID: 27977700
  7. 7

    Properties of beta oscillations in Dup15q syndrome.

    Saravanapandian V, Frohlich J, Hipp JF, et al.

    Journal of neurodevelopmental disorders 2020; (12(1)):22 doi:10.1186/s11689-020-09326-1.

    PMID: 32791992
  8. 8

    Abnormal sleep physiology in children with 15q11.2-13.1 duplication (Dup15q) syndrome.

    Saravanapandian V, Nadkarni D, Hsu SH, et al.

    Molecular autism 2021; (12(1)):54 doi:10.1186/s13229-021-00460-8.

    PMID: 34344470
  9. 9

    Mechanisms underlying the EEG biomarker in Dup15q syndrome.

    Frohlich J, Reiter LT, Saravanapandian V, et al.

    Molecular autism 2019; (10()):29 doi:10.1186/s13229-019-0280-6.

    PMID: 31312421
  10. 10

    Acute lymphoblastic leukemia in a nine-year-old girl with isodicentric chromosome 15 syndrome.

    Antonucci R, Vacca N, Ghisu E, et al.

    Cancer genetics 2019; (235-236()):93-94 doi:10.1016/j.cancergen.2019.05.001.

    PMID: 31155481
  11. 11

    Sleep EEG signatures in mouse models of 15q11.2-13.1 duplication (Dup15q) syndrome.

    Saravanapandian V, Madani M, Nichols I, et al.

    Journal of neurodevelopmental disorders 2024; (16(1)):39 doi:10.1186/s11689-024-09556-7.

    PMID: 39014349
  12. 12

    [Effect of prednisolone and adrenocorticotropic hormone in the treatment of infantile spasms: a Meta analysis].

    Luo KR, Tang J, Mu DZ

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(7)):656-662.

    PMID: 31315764
  13. 13

    Genomics of Complex Neurodevelopmental Disorders with Variable Epilepsy Phenotypes: A Clinical Review of Dup15q Syndrome.

    Thodeson D, Lockard T, Koh S

    Genes 2026; (17(2)) doi:10.3390/genes17020163.

    PMID: 41751547
  14. 14

    Efficacy, safety, and tolerability of soticlestat as adjunctive therapy for the treatment of seizures in patients with Dup15q syndrome or CDKL5 deficiency disorder in an open-label signal-finding phase II study (ARCADE).

    Demarest S, Jeste S, Agarwal N, et al.

    Epilepsy & behavior : E&B 2023; (142()):109173 doi:10.1016/j.yebeh.2023.109173.

    PMID: 37011526
  15. 15

    Electroconvulsive therapy in autism spectrum disorders: an update to the literature.

    Wachtel L, Luccarelli J, Falligant JM, Smith JR

    Current opinion in psychiatry 2025; (38(2)):79-86 doi:10.1097/YCO.0000000000000985.

    PMID: 39804212
  16. 16

    Use of En-Bloc Multiple Monitored Electroconvulsive Therapy in Benzodiazepine Refractory Malignant Catatonia.

    Louie AT, Anand E, Baldwin I, Smith JR

    The journal of ECT 2025; (41(1)):62-65 doi:10.1097/YCT.0000000000001020.

    PMID: 38968433
  17. 17

    Risk of SUDEP during infancy.

    Trivisano M, Muccioli L, Ferretti A, et al.

    Epilepsy & behavior : E&B 2022; (131(Pt B)):107896 doi:10.1016/j.yebeh.2021.107896.

    PMID: 33741238
  18. 18

    Real-World Practices in Educating Patients and Caregivers About Sudden Unexpected Death in Epilepsy: A Scoping Review.

    Alzahrani LA, Aldweesh AF, Alotaibi AN, et al.

    Saudi journal of medicine & medical sciences 2026; (14(1)):4-13 doi:10.4103/sjmms.sjmms_114_25.

    PMID: 41675952
  19. 19

    Advances in sudden unexpected death in epilepsy.

    Zhao H, Long L, Xiao B

    Acta neurologica Scandinavica 2022; (146(6)):716-722 doi:10.1111/ane.13715.

    PMID: 36358030
  20. 20

    A systematic review of sudden unexpected death in epilepsy (SUDEP) in childhood.

    Abdel-Mannan O, Taylor H, Donner EJ, Sutcliffe AG

    Epilepsy & behavior : E&B 2019; (90()):99-106 doi:10.1016/j.yebeh.2018.11.006.

    PMID: 30522060
  21. 21

    Sudden unexpected death in epilepsy: measures to reduce risk.

    Mclean B, Shankar R, Hanna J, et al.

    Practical neurology 2017; (17(1)):13-20 doi:10.1136/practneurol-2016-001392.

    PMID: 27903766

This page provides educational information on epilepsy management in idic15 and Dup15q syndrome. Always consult your pediatric neurologist or epileptologist before making any changes to your child's seizure action plan or medications.

Get notified when new evidence is published on Inverted duplicated chromosome 15 syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.